|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn815470914 |
003 |
OCoLC |
005 |
20231117044748.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
121005s2003 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCO
|d OPELS
|d N$T
|d OCLCF
|d COO
|d YDXCP
|d EBLCP
|d MHW
|d UKDOC
|d DEBSZ
|d OCLCQ
|d LEAUB
|d OCLCQ
|d VLY
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 843638008
|a 850149346
|a 905494980
|a 1162251494
|
020 |
|
|
|a 9780080923888
|q (electronic bk.)
|
020 |
|
|
|a 0080923887
|q (electronic bk.)
|
020 |
|
|
|z 0123932246
|
020 |
|
|
|z 9780123932242
|
020 |
|
|
|a 9786613931917
|
020 |
|
|
|a 6613931918
|
020 |
|
|
|a 1283619466
|
020 |
|
|
|a 9781283619462
|
020 |
|
|
|a 9786613931993
|
020 |
|
|
|a 6613931993
|
020 |
|
|
|a 1283619547
|
020 |
|
|
|a 9781283619547
|
020 |
|
|
|a 0080923852
|
020 |
|
|
|a 9780080923857
|
020 |
|
|
|a 9786613931948
|
020 |
|
|
|a 6613931942
|
020 |
|
|
|a 1283619490
|
020 |
|
|
|a 9781283619493
|
035 |
|
|
|a (OCoLC)815470914
|z (OCoLC)843638008
|z (OCoLC)850149346
|z (OCoLC)905494980
|z (OCoLC)1162251494
|
050 |
|
4 |
|a QD441
|b .P48 2003eb
|
072 |
|
7 |
|a SCI
|x 013040
|2 bisacsh
|
082 |
0 |
4 |
|a 547/.869
|2 23
|
245 |
0 |
0 |
|a Phthalocyanines :
|b medical aspects of porphyrins /
|c editors Karl M. Kadish, Kevin M. Smith, Roger Guilard.
|
260 |
|
|
|a Amsterdam :
|b Academic Press,
|c 2003.
|
300 |
|
|
|a 1 online resource (xl, 347 pages :) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a The porphyrin handbook ;
|v v. 14
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Front Cover; The Porphyrin Handbook: Medical Aspects of Porphyrins; Copyright Page; Table of Contents; Preface; Chapter 85. Erythropoietic Disorders Involving Heme Biosynthesis; I. Introduction; II. Sideroblastic Anemias; III. Lead Poisoning; IV. Porphyrias; V. Iron-Deficient Erythropoiesis; VI. Animal Models; References; Chapter 86. Acute Intermittent Porphyria: From Clinical to Molecular Aspects; I. Introduction and Classification of Human Porphyrias; II. Acute Intermittent Porphyria; III. Treatment of Acute Attacks; IV. Summary; References; Chapter 87. Congenital Erythropoietic Porphyria.
|
505 |
8 |
|
|a I. IntroductionII. Clinical Findings in CEP; III. Enzymology and Biochemical Findings; IV. Molecular Biology and Pathology; V. Physiopathology; VI. Diagnosis; VII. Treatment; References; Chapter 88. Porphyria Cutanea Tarda and Related Disorders; I. Introduction; II. The Human UROD Locus; III. Human Uroporphyrinogen Decarboxylase (UROD); IV. Molecular Pathology and Classification of UROD Deficiency Disorders; V. Porphyria Cutanea Tarda; VI. Hepatoerythropoietic Porphyria; References; Chapter 89. Variegate Porphyria; I. Introduction; II. History and Prevalence.
|
505 |
8 |
|
|a III. Heme Biosynthetic Enzymes in Variegate Porphyria (VP)IV. Diagnosis of VP; V. Clinical Features of VP; VI. Homozygous VP; VII. Conclusion; References; Chapter 90. Protoporphyria; I. Protoporphyria; II. Definition and History; III. Prevalence of Protoporphyria; IV. Clinical Features; V. Pathological Features of Protoporphyria; VI. Biochemical Abnormalities; VII. Pathogenesis; VIII. Clinical and Molecular Genetics of Protoporphyria; IX. Diagnosis of Protoporphyria; X. Treatment; XI. Future Directions in Protoporphyria Research; XII. Summary; References.
|
505 |
8 |
|
|a Chapter 91. Miscellaneous Abnormalities in Porphyrin Production and DisposalI. Introduction; II. Porphyrin Excretion in Bile and Urine; III. Secondary Porphyrinopathies; IV. The Bronze Baby Syndrome; V. The Multiple Chemical Sensitivity Syndrome; VI. Porphyrin Abnormalities in Response to Lead and Other Industrial Toxins; VII. Pseudoporphyria; VIII. Disturbances in Porphyrin Metabolism and Excretion Associated with Renal Disease; IX. Porphyrin Disturbances in Carcinomatosis; X. Familial Conjugated Hyperbilirubinaemias; References.
|
505 |
8 |
|
|a Chapter 92. Porphyria Caused by Chlorinated AH Receptor Ligands and Associated Mechanisms of Liver InjuryI. Introduction; II. Known Porphyrogenic Polyhalogenated Aromatic Chemicals; III. Porphyria and Porphyrinuria in Man; IV. Experimental Porphyria in Animals by Polyhalogenated Aromatic Chemical; V. Metabolic Responses; VI. Mechanistic Hypotheses of Uroporphyria; VII. Liver Injury and Cancer Associated with Porphyria; VIII. Summary; References; Chapter 93. Porphyria: A Diagnostic Approach; I. Introduction; II. Approach to the Diagnosis of the Porphyrias.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Phthalocyanines.
|
650 |
|
0 |
|a Porphyrins.
|
650 |
|
6 |
|a Phtalocyanines.
|0 (CaQQLa)201-0049014
|
650 |
|
6 |
|a Porphyrines.
|0 (CaQQLa)201-0049015
|
650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Organic.
|2 bisacsh
|
650 |
|
7 |
|a Phthalocyanines.
|2 fast
|0 (OCoLC)fst01062248
|
650 |
|
7 |
|a Porphyrins.
|2 fast
|0 (OCoLC)fst01071936
|
700 |
1 |
|
|a Kadish, Karl M.,
|d 1945-
|
700 |
1 |
|
|a Smith, Kevin M.
|
700 |
1 |
|
|a Guilard, Roger.
|
776 |
0 |
8 |
|i Print version:
|a Kadish, Karl.
|t Porphyrin Handbook : Medical Aspects of Porphyrins.
|d Burlington : Elsevier Science, �2006
|z 9780123932242
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080923888
|z Texto completo
|